XML 22 R12.htm IDEA: XBRL DOCUMENT

Balance Sheets - Additional Information

9 Months Ended

Mar. 31, 2022

Balance Sheets-Additional Information

4. Balance Sheets—Additional Information


	March 31,		June 30,
As of	2022		2021
Inventories
Raw materials	$	85,255	$	59,775
Work-in-process		12,900		12,738
Finished goods		151,756		143,799
	$	249,911	$	216,312


	March 31,		June 30,
As of	2022		2021
Other assets
ROU operating lease assets	$	38,691	$	32,962
Deferred income taxes		4,097		9,861
Deposits		6,293		5,663
Insurance investments		6,054		5,964
Equity method investments		4,063		4,141
Derivative instruments		14,560		2,696
U.S. pension plan		2,482		1,184
Debt issuance costs		1,530		1,811
Other		8,774		8,467
	$	86,544	$	72,749

In February 2022, we acquired a business for $13,728, of which $3,166 is outstanding at March 31, 2022 and payable during the fourth quarter ending June 30, 2022. The business develops, manufactures and markets processing aids used to improve production efficiency in the ethanol fermentation industry. We accounted for the acquisition as a business combination in accordance with ASC 805, Business Combinations. Pro forma information giving effect to the acquisition has not been provided because the results are not material to the consolidated financial statements. Definite-lived intangible assets of $10,833 were recognized at acquisition and included developed products, tradename, and non-compete agreements. The definite-lived intangible assets will be amortized over periods ranging from 4 to 13 years. The remaining net assets acquired include accounts receivable, inventories, prepaid and other assets, accounts payable, accrued expenses, and goodwill. Goodwill is deductible for income tax purposes. The purchase price

allocation is preliminary and subject to change, including final working capital adjustments. The business is included in the MFAs and other product category under the Animal Health segment.


	March 31,		June 30,
As of	2022		2021
Goodwill
Balance at beginning of period	$	52,679	$	52,679
Acquisition		595		—
Foreign currency translation		47		—
Balance at end of period	$	53,321	$	52,679


	March 31,		June 30,
As of	2022		2021
Accrued expenses and other current liabilities
Employee related	$	30,601	$	35,375
Current operating lease liabilities		6,431		6,618
Commissions and rebates		6,528		6,312
Professional fees		6,057		4,380
Income and other taxes		7,890		6,107
Derivative instruments		391		3,486
Contingent consideration		—		4,840
Restructuring costs		—		735
Insurance-related		1,179		1,176
Other		23,329		17,350
	$	82,406	$	86,379


	March 31,		June 30,
As of	2022		2021
Other liabilities
Long-term operating lease liabilities	$	33,632	$	28,003
Long-term and deferred income taxes		8,848		6,646
Supplemental retirement benefits, deferred compensation and other		8,487		8,382
International retirement plans		4,821		5,345
Other long-term liabilities		5,725		7,594
	$	61,513	$	55,970


	March 31,		June 30,
As of	2022		2021
Accumulated other comprehensive loss
Derivative instruments	$	18,949	$	(790)
Foreign currency translation adjustment		(113,856)		(100,095)
Unrecognized net pension losses		(19,619)		(19,973)
(Provision) benefit for income taxes on derivative instruments		(4,838)		97
Benefit for income taxes on long-term intercompany investments		8,166		8,166
Provision for income taxes on net pension losses		(2,786)		(2,698)
	$	(113,984)	$	(115,293)